Nere ML - Search Results

1

Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV-1 infected patients in 2020-2023.

Chaix ML, Terracol L, Nere ML, Stefic K, Lascoux-Combe C, Manda V, Sellier P, Maylin S, Molina JM, Liegeon G, Delaugerre C, Salmona M. Chaix ML, et al. Among authors: nere ml. J Med Virol. 2024 Oct;96(10):e29948. doi: 10.1002/jmv.29948. J Med Virol. 2024. PMID: 39363782

2

Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen.

Delaugerre C, Charreau I, Braun J, Néré ML, de Castro N, Yeni P, Ghosn J, Aboulker JP, Molina JM, Simon F; ANRS 138 study group. Delaugerre C, et al. Among authors: nere ml. AIDS. 2010 Sep 24;24(15):2391-5. doi: 10.1097/QAD.0b013e32833d214c. AIDS. 2010. PMID: 20683319 Clinical Trial.

3

Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication.

Delaugerre C, Braun J, Charreau I, Delarue S, Nere ML, de Castro N, May T, Marchou B, Simon F, Molina JM, Aboulker JP; ANRS 138-EASIER study group. Delaugerre C, et al. Among authors: nere ml. HIV Med. 2012 Oct;13(9):517-25. doi: 10.1111/j.1468-1293.2012.01002.x. Epub 2012 Mar 14. HIV Med. 2012. PMID: 22416781 Free article. Clinical Trial.

4

Archived HIV-1 DNA resistance mutations to rilpivirine and etravirine in successfully treated HIV-1-infected individuals pre-exposed to efavirenz or nevirapine.

Gallien S, Charreau I, Nere ML, Mahjoub N, Simon F, de Castro N, Aboulker JP, Molina JM, Delaugerre C. Gallien S, et al. Among authors: nere ml. J Antimicrob Chemother. 2015 Feb;70(2):562-5. doi: 10.1093/jac/dku395. Epub 2014 Oct 25. J Antimicrob Chemother. 2015. PMID: 25344807 Clinical Trial.

5

Unravelling the dynamics of selection of multiresistant variants to integrase inhibitors in an HIV-1-infected child using ultra-deep sequencing.

Stefic K, Salmona M, Capitao M, Splittgerber M, Maakaroun-Vermesse Z, Néré ML, Bernard L, Chaix ML, Barin F, Delaugerre C. Stefic K, et al. Among authors: nere ml. J Antimicrob Chemother. 2017 Mar 1;72(3):850-854. doi: 10.1093/jac/dkw507. J Antimicrob Chemother. 2017. PMID: 27999055

6

Detectable HIV-RNA in semen of HIV controllers.

Chaix ML, Boufassa F, Meyzer C, Leruez-Ville M, Mahjoub N, Nere ML, Genet P, Duvivier C, Lascoux-Combes C, Lambotte O, Ghosn J. Chaix ML, et al. Among authors: nere ml. PLoS One. 2017 Aug 16;12(8):e0183376. doi: 10.1371/journal.pone.0183376. eCollection 2017. PLoS One. 2017. PMID: 28813503 Free PMC article.

7

Drug resistance among patients who acquired HIV infection in a preexposure prophylaxis trial.

Delaugerre C, Rodriguez C, Capitant C, Nere ML, Mercier-Darty M, Carette D, Pialoux G, Cotte L, Charreau I, Molina JM; IPERGAY study group. Delaugerre C, et al. Among authors: nere ml. AIDS. 2018 Oct 23;32(16):2353-2361. doi: 10.1097/QAD.0000000000001960. AIDS. 2018. PMID: 30096070

8

Ultra-deep sequencing improves the detection of drug resistance in cellular DNA from HIV-infected patients on ART with suppressed viraemia.

Rodriguez C, Nere ML, Demontant V, Charreau I, Mercier-Darty M, Delagreverie H, Salmona M, de Castro N, Chaix ML, Molina JM, Delaugerre C. Rodriguez C, et al. Among authors: nere ml. J Antimicrob Chemother. 2018 Nov 1;73(11):3122-3128. doi: 10.1093/jac/dky315. J Antimicrob Chemother. 2018. PMID: 30137335

9

Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.

Palich R, Ghosn J, Chaillon A, Boilet V, Nere ML, Chaix ML, Delobel P, Molina JM, Lucht F, Bouchaud O, Rieux V, Thiebaut R, Levy Y, Delaugerre C, Lelievre JD; VRI02/ANRS149 LIGHT Vaccine Trial Group. Palich R, et al. Among authors: nere ml. AIDS. 2019 Feb 1;33(2):279-284. doi: 10.1097/QAD.0000000000002058. AIDS. 2019. PMID: 30325777

10

Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants.

Delagreverie HM, Grude M, Lambert-Niclot S, Nere ML, Jadand C, Leport C, Raffi F, Ghislain M, Goujard C, Meyer L, Calvez V, Katlama C, Flandre P, Barin F, Delaugerre C. Delagreverie HM, et al. Among authors: nere ml. J Antimicrob Chemother. 2019 May 1;74(5):1389-1394. doi: 10.1093/jac/dkz004. J Antimicrob Chemother. 2019. PMID: 30690509 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters